Emerald Health Therapeutics, Inc. (EMHTF)
Emerald Health Therapeutics, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.04, up 55.17% on the session, giving a market capitalisation of $0. On trailing twelve-month figures it carries a trailing P/E of -0.27, a net margin of -411.9%. Its beta of 0.63 implies it has historically moved less than the broad market.
Emerald Health Therapeutics, Inc. (EMHTF) is a Canadian entity engaged in the cultivation, distribution, and sale of cannabis for both recreational and medical markets throughout Canada. The company offers a wide range of cannabis products, including dried flower, pre-rolls, oral sprays, advanced nano emulsion beverages, and various cannabis oil formulations. These products are marketed under distinct brands such as SYNC Wellness, fuse, Emerald, and Souvenir. Initially founded as T-Bird Pharma Inc., the organization rebranded to Emerald Health Therapeutics, Inc. in June 2015. Headquartered in Vancouver, Canada, Emerald Health Therapeutics, Inc. has been operating as a subsidiary of Skye Bioscience, Inc. since November 10, 2022.
Emerald Health Therapeutics, Inc. is most often compared with the following Healthcare names: